BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31704958)

  • 21. Crystal structure of yeast DNA polymerase ε catalytic domain.
    Jain R; Rajashankar KR; Buku A; Johnson RE; Prakash L; Prakash S; Aggarwal AK
    PLoS One; 2014; 9(4):e94835. PubMed ID: 24733111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender.
    Jha V; Ling H
    J Mol Biol; 2018 May; 430(11):1577-1589. PubMed ID: 29715472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk between replicative and translesional DNA polymerases: PDIP38 interacts directly with Poleta.
    Tissier A; Janel-Bintz R; Coulon S; Klaile E; Kannouche P; Fuchs RP; Cordonnier AM
    DNA Repair (Amst); 2010 Aug; 9(8):922-8. PubMed ID: 20554254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η.
    Kalhor S; Fattahi A
    Sci Rep; 2022 Nov; 12(1):18461. PubMed ID: 36323739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatched base-pair simulations for ASFV Pol X/DNA complexes help interpret frequent G*G misincorporation.
    Sampoli Benítez BA; Arora K; Balistreri L; Schlick T
    J Mol Biol; 2008 Dec; 384(5):1086-97. PubMed ID: 18955064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
    Chromik J; Safferthal C; Serve H; Fulda S
    Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct mechanisms of cis-syn thymine dimer bypass by Dpo4 and DNA polymerase eta.
    Johnson RE; Prakash L; Prakash S
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12359-64. PubMed ID: 16116089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.
    Wiley JS; Jones SP; Sawyer WH; Paterson AR
    J Clin Invest; 1982 Feb; 69(2):479-89. PubMed ID: 6948829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Snapshots of a Y-family DNA polymerase in replication: substrate-induced conformational transitions and implications for fidelity of Dpo4.
    Wong JH; Fiala KA; Suo Z; Ling H
    J Mol Biol; 2008 May; 379(2):317-30. PubMed ID: 18448122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Evaluation of Nucleotide Insertion Opposite Expanded and Widened DNA by the Translesion Synthesis Polymerase Dpo4.
    Albrecht L; Wilson KA; Wetmore SD
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of inosine into DNA by human polymerase eta (Polη): kinetics of nucleotide misincorporation and structural basis for the mutagenicity.
    Zhang Q; Tretyakova N
    Biochem J; 2023 Sep; 480(18):1479-1483. PubMed ID: 37746864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of an archaebacterial DNA polymerase.
    Zhao Y; Jeruzalmi D; Moarefi I; Leighton L; Lasken R; Kuriyan J
    Structure; 1999 Oct; 7(10):1189-99. PubMed ID: 10545321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic and mechanistic insights into translesion DNA synthesis catalyzed by Y-family DNA polymerase across a bulky double-base lesion of an antitumor platinum drug.
    Brabec V; Malina J; Margiotta N; Natile G; Kasparkova J
    Chemistry; 2012 Nov; 18(48):15439-48. PubMed ID: 23065963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.
    Zheng R; Studzinski GP
    J Cell Biochem; 2017 Jun; 118(6):1583-1589. PubMed ID: 27922189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytarabine conjugates with biologically active molecules and their potential anticancer activity.
    Novotny L; Rauko P
    Neoplasma; 2009; 56(3):177-86. PubMed ID: 19309219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bypass of the Major Alkylative DNA Lesion by Human DNA Polymerase η.
    Koag MC; Jung H; Kou Y; Lee S
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational Flexibility of the Benzyl-Guanine Adduct in a Bypass Polymerase Active Site Permits Replication: Insights from Molecular Dynamics Simulations.
    Wilson KA; Wetmore SD
    Chem Res Toxicol; 2017 Nov; 30(11):2013-2022. PubMed ID: 28810119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative differences between replicative and repair synthesis of DNA in normal and transformed mouse cells as measured by precursor discrimination.
    Elliott GC; Downes CS
    Mutat Res; 1986 Nov; 166(3):295-302. PubMed ID: 3097531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.